Clue to cancer treatment found in urine

Wilton, Peter
September 1998
CMAJ: Canadian Medical Association Journal;09/08/98, Vol. 159 Issue 5, p436
Academic Journal
Focuses on research by Jeffrey Charuk and colleagues, of the University of Toronto, on nonylphenol ethoxylate. The substance, known as nonoxynol, finding its way into the human body and food chain; Findings reported in the 1998 issue of `American Journal of Physiology'; Mention of the relationship of nonoxynol to the 1970s discovery of Canadian scientist Victor Ling on P-glycoprotein and resistant cancer cells.


Related Articles

  • Cancer biology: Cancer mutation has a long reach.  // Nature;8/29/2013, Vol. 500 Issue 7464, p505 

    The article offers information on the distant oestrogen response elements (DEREs), which supports the genetic material to form loops for interaction with genomic regions to promote the cancer mutation.

  • P-glycoprotein as a Drug Target in the Treatment of Multidrug Resistant Cancer. Lehne, Gustav // Current Drug Targets;Jul2000, Vol. 1 Issue 1, p85 

    Multidrug resistance (MDR) is a major obstacle to successful cancer chemotherapy. One important mechanism of MDR involves the multidrug transporter, P-glycoprotein (Pgp), which confers upon cancer cells the ability to resist lethal doses of certain cytotoxic drugs by pumping the drugs out of the...

  • Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging. Tatsumi, Mitsuaki; Tsuruo, Takashi; Nishimura, Tsunehiko // European Journal of Nuclear Medicine & Molecular Imaging;2002, Vol. 29 Issue 3, p288 

    MS-209 is a newly synthesised multidrug-resistance (MDR)-reversing agent with few side-effects. In this study, we evaluated the effect of MS-209 on P-glycoprotein (Pgp)-positive tumours in mice by means of technetium-99m methoxyisobutylisonitrile (MIBI) imaging. Mice received Pgp-negative KB-3-1...

  • The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar. Taylor, J C; Ferry, D R; Higgins, C F; Callaghan, R // British Journal of Cancer;11/1/99, Vol. 81 Issue 5, p783 

    The gene encoding the multidrug resistance P-glycoprotein (P-gp) is duplicated in rodent species and the functional basis for this remains unresolved. Despite a high sequence similarity, the mouse P-gp1a and P-gp1b isoforms show distinct patterns of tissue distribution which suggest a specific...

  • Selective modulation of P-glycoprotein-mediated drug resistance. Bebawy, M; Morris, M B; Roufogalis, B D // British Journal of Cancer;12/15/2001, Vol. 85 Issue 12, p1998 

    Multidrug resistance associated with the overexpression of the multidrug transporter P-glycoprotein is a serious impediment to successful cancer treatment. We found that verapamil reversed resistance of CEM/VLB[SUB100] cells to vinblastine and fluorescein-colchicine, but not to colchicine....

  • Monoclonal antibodies specific for P-glycoprotein. Okochi, E; Iwahashi, T; Tsuruo, T // Leukemia (08876924);Jul97, Vol. 11 Issue 7, p1119 

    Multidrug resistance (MDR) is one of the major obstacles to successful cancer chemotherapy. Since P-glycoprotein (P-gp) encoded by the MDR-1 gene plays a key role in MDR, many P-gp-specific monoclonal antibodies (MAbs) have been generated for characterization and analysis of P-gp. Among those...

  • Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents. Lehne, G; De Angelis, P; den Boer, M; Rugstad, H E // Leukemia (08876924);May99, Vol. 13 Issue 5, p768 

    The multidrug transporter P-glycoprotein (Pgp), which is frequently overexpressed in multidrug resistant leukemia, has many proposed physiological functions including involvement in transmembraneous transport of certain growth-regulating cytokines. Therefore, we studied cell growth of three...

  • Clinical pharmacology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS12 

    Presents an abstract of the research manuscript `P-glycoprotein-mediated drug transport by Caco-2 cells,' by R.B. Kim, C. Wandel et al from the Vanderbilt University.

  • Decitabine (5-Aza-2′-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells. Ando, T; Nishimura, M; Oka, Y // Leukemia (08876924);Nov2000, Vol. 14 Issue 11, p1915 

    Multidrug resistance (MDR) is a major problem in patients with hematological malignancies. Although drug-resistance is known to be induced by the expression of P-glycoprotein (P-gp) encoded by the MDR-1 gene, little is known about the mechanisms regulating this gene. Herein, we studied the DNA...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics